Fulton Bank N.A. Trims Holdings in Danaher Co. (NYSE:DHR)

Fulton Bank N.A. decreased its stake in shares of Danaher Co. (NYSE:DHR) by 6.9% during the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 10,236 shares of the conglomerate’s stock after selling 762 shares during the quarter. Fulton Bank N.A.’s holdings in Danaher were worth $2,846,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. Prentice Wealth Management LLC lifted its position in Danaher by 4.6% during the third quarter. Prentice Wealth Management LLC now owns 2,662 shares of the conglomerate’s stock worth $740,000 after buying an additional 117 shares in the last quarter. Value Partners Investments Inc. increased its stake in Danaher by 9.7% during the third quarter. Value Partners Investments Inc. now owns 1,854 shares of the conglomerate’s stock worth $515,000 after acquiring an additional 164 shares during the last quarter. Parisi Gray Wealth Management increased its stake in Danaher by 0.5% during the third quarter. Parisi Gray Wealth Management now owns 15,676 shares of the conglomerate’s stock worth $4,358,000 after acquiring an additional 74 shares during the last quarter. Miracle Mile Advisors LLC acquired a new stake in Danaher during the third quarter worth $310,000. Finally, Diversified Trust Co increased its stake in Danaher by 29.6% during the third quarter. Diversified Trust Co now owns 5,649 shares of the conglomerate’s stock worth $1,571,000 after acquiring an additional 1,289 shares during the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Wall Street Analyst Weigh In

DHR has been the subject of several recent analyst reports. Barclays raised their target price on Danaher from $270.00 to $285.00 and gave the stock an “equal weight” rating in a research note on Wednesday, July 24th. TD Cowen raised their target price on Danaher from $290.00 to $310.00 and gave the stock a “buy” rating in a research note on Wednesday, July 24th. Stifel Nicolaus raised their target price on Danaher from $235.00 to $250.00 and gave the stock a “hold” rating in a research note on Wednesday, July 24th. Evercore ISI lifted their price objective on Danaher from $275.00 to $278.00 and gave the company an “outperform” rating in a research note on Tuesday, October 1st. Finally, Leerink Partners lifted their price objective on Danaher from $275.00 to $280.00 and gave the company an “outperform” rating in a research note on Wednesday, July 24th. Seven equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to MarketBeat.com, Danaher has an average rating of “Moderate Buy” and a consensus price target of $282.12.

Insider Transactions at Danaher

In other Danaher news, SVP Brian W. Ellis sold 9,600 shares of Danaher stock in a transaction on Thursday, July 25th. The shares were sold at an average price of $275.16, for a total value of $2,641,536.00. Following the completion of the transaction, the senior vice president now owns 20,230 shares of the company’s stock, valued at $5,566,486.80. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this link. In other news, CEO Rainer Blair sold 9,007 shares of the company’s stock in a transaction that occurred on Wednesday, July 31st. The stock was sold at an average price of $280.00, for a total transaction of $2,521,960.00. Following the completion of the transaction, the chief executive officer now directly owns 97,983 shares of the company’s stock, valued at approximately $27,435,240. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Brian W. Ellis sold 9,600 shares of the firm’s stock in a transaction that occurred on Thursday, July 25th. The stock was sold at an average price of $275.16, for a total value of $2,641,536.00. Following the completion of the sale, the senior vice president now directly owns 20,230 shares in the company, valued at approximately $5,566,486.80. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 39,659 shares of company stock valued at $11,042,433. Insiders own 11.10% of the company’s stock.

Danaher Stock Down 0.5 %

Shares of NYSE:DHR traded down $1.24 during mid-day trading on Monday, hitting $268.79. 1,153,165 shares of the company traded hands, compared to its average volume of 2,751,341. The firm has a market cap of $199.09 billion, a P/E ratio of 45.56, a PEG ratio of 4.55 and a beta of 0.83. Danaher Co. has a 52-week low of $182.09 and a 52-week high of $281.70. The firm’s 50 day simple moving average is $271.07 and its 200 day simple moving average is $258.64. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.04 and a current ratio of 1.43.

Danaher (NYSE:DHR) last released its quarterly earnings results on Tuesday, July 23rd. The conglomerate reported $1.72 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.57 by $0.15. Danaher had a net margin of 16.94% and a return on equity of 11.06%. The firm had revenue of $5.74 billion for the quarter, compared to the consensus estimate of $5.59 billion. During the same quarter in the previous year, the firm posted $2.05 EPS. The firm’s quarterly revenue was down 2.9% on a year-over-year basis. On average, equities analysts anticipate that Danaher Co. will post 7.59 EPS for the current year.

Danaher Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, October 25th. Stockholders of record on Friday, September 27th will be given a $0.27 dividend. This represents a $1.08 annualized dividend and a dividend yield of 0.40%. The ex-dividend date is Friday, September 27th. Danaher’s payout ratio is currently 18.31%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.